help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on April 14, 2005, doi:10.1164/rccm.200409-1244OC

Am. J. Respir. Crit. Care Med., Volume 172, Number 1, July 2005, 99-104

A more recent version of this article appeared on July 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200409-1244OCv1
172/1/99    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dobbin, C. J
Right arrow Articles by Bye, P. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dobbin, C. J
Right arrow Articles by Bye, P. P.

Submitted on September 20, 2004
Accepted on April 12, 2005

The Effect of Infective Exacerbations on Sleep and Neurobehavioural Function in Cystic Fibrosis

Catherine J Dobbin1*, Delwyn Bartlett2, Kerri Melehan1, Ronald R Grunstein3, and Peter PT Bye1

1 Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown, Australia, 2 Woolcock Institute for Medical Research, Sydney, Australia, 3 Sleep Research Group, Woolcock Institute for Medical Research, University of Sydney, Sydney, Australia

* To whom correspondence should be addressed. E-mail: cathd{at}mail.med.usyd.edu.au.

Rationale: Adults with CF are susceptible to hypoxemia, hypercapnia, arousal from sleep and neurobehavioural impairment. Objectives: We hypothesised that pulmonary exacerbations would adversely affect sleep and neurobehavioural performance. Methods: Patients with exacerbations (cases) had sleep studies and neurobehavioural testing before and after inpatient intravenous therapy. Stable CF adults underwent the same testing procedures (controls). Measurements and Main Results: When clinically stable, cases and controls had similar lung function, intelligence and BMI. Amongst cases, treatment of an exacerbation improved lung function, quality of life, mood, sleepiness and activation. Cases spent more time awake after sleep onset (p=0.02), less time in REM sleep (p=0.03) and were more hypoxemic than controls when unwell. The severity of hypoxemia correlated with lung function. On admission, cases had slower throughput than controls in the serial addition and subtraction task (SAST) (cases 16±4 versus controls 17±3; F(1,36)=5.15, p=0.03) and a slower response time on the digit symbol substitution task (F(1,36)=11.91, p=0.001), which persisted after treatment (F(1,36)=8.48, p=0.006). Cases experienced significant improvements in sleep efficiency, amount of REM sleep and hypoxia with treatment. Their performance in the SAST, psychomotor vigilance task and simulated driving task also improved with treatment. Gender modified the effect of an exacerbation on some aspects of performance. Conclusions: Exacerbations of lung disease in adults with CF adversely affect sleep and tests of neurobehavioural performance regardless of underlying disease severity. The implications for performance in daily life need further evaluation as patients often delay admission to hospital in order to fulfil study or work commitments.


Key words: Infective exacerbations, Sleep architecture, Sleep-disordered breathing, Neurobehavioural function




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
C. H. Goss and A. L. Quittner
Patient-reported Outcomes in Cystic Fibrosis
Proceedings of the ATS, August 1, 2007; 4(4): 378 - 386.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S. C Bell and P. J Robinson
Exacerbations in cystic fibrosis: 2 {middle dot} Prevention
Thorax, August 1, 2007; 62(8): 723 - 732.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. R. Casey, K. O. Cantillo, and L. K. Brown
Sleep-Related Hypoventilation/Hypoxemic Syndromes
Chest, June 1, 2007; 131(6): 1936 - 1948.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
C. H Goss and J. L Burns
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Thorax, April 1, 2007; 62(4): 360 - 367.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J K Block, K L Vandemheen, E Tullis, D Fergusson, S Doucette, D Haase, Y Berthiaume, N Brown, P Wilcox, P Bye, et al.
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria
Thorax, November 1, 2006; 61(11): 969 - 974.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. J. Accurso
Update in cystic fibrosis 2005.
Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 944 - 947.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
D S Urquhart, H Montgomery, and A Jaffe
Assessment of hypoxia in children with cystic fibrosis
Arch. Dis. Child., November 1, 2005; 90(11): 1138 - 1143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  Tobacco